Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Multiple sclerosis shrinks intralesional, and enlarges extralesional, brain parenchymal veins.
[Neuromyelitis optica.]
The gut microbiota and its correlations with the central nervous system disorders.
The influence of tetracyclines on T cell activation.
Effect of open label pulse cyclophosphamide therapy on MRI measures of disease activity in five patients with refractory relapsing-remitting multiple sclerosis.
Haplotypes across the human caveolin 1 gene upstream purine complex significantly alter gene expression: Implication in neurodegenerative disorders.
Aquaporins: important but elusive drug targets.
[Physical rehabilitation in multiple sclerosis: general principles and high-tech approaches].
Synthon Announces Successful Outcomes from the Open-label extension of the Phase III GATE Study of Synthon’s Glatiramer Acetate
A pilot study of the immunological effects of high-dose vitamin D in healthy volunteers.
Simultaneous PML-IRIS after discontinuation of natalizumab in a patient with MS.
[HTLV-1-associated myelopathy/tropical spastic paraparesis : A differential diagnosis in multiple sclerosis.]
Diffusion tensor imaging of the corticospinal tract and walking performance in multiple sclerosis.
Symptoms, Prevalence and Impact of Multiple Sclerosis in Younger Patients: A Multinational Survey.
Protective effect of tanreqing injection on axon myelin damage in the brain of mouse model for experimental autoimmune encephalomyelitis.
Brainstem PML lesion mimicking MS plaque in a natalizumab-treated MS patient.
The effect of gabapentin on oxidative stress in a model of toxic demyelination in rat brain.
Rebound after Fingolimod suspension in a pediatric-onset multiple sclerosis patient.
Impact of Clear, Loud and Slow Speech on Scaled Intelligibility and Speech Severity in Parkinson's Disease and Multiple Sclerosis.
Bilateral hearing loss as a manifestation of neuromyelitis optica.
Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ
Monoclonal Antibodies in the Treatment of Neuroimmunological Diseases.
Multifocal visual evoked potentials are influenced by variable contrast stimulation in MS.
[Autophagy and its role in protective and damaging inflammatory response].
Metals and Neurodegeneration.
Pages
« first
‹ previous
…
207
208
209
210
211
212
213
214
215
…
next ›
last »